Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04194554 |
Title | A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS) |
Acronym | ASCLEPIuS |
Recruitment | Active, not recruiting |
Gender | male |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | University of Michigan Rogel Cancer Center |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |